Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CYP1A2 Polymorphisms and Theophylline Metabolism in COPD
NCT03015090Completed
- Start
- Jan 2017
- Primary completion
- Jun 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of theophylline in chronic obstructive pulmonary disease (COPD). Primary endpoint: Plasma concentrations of theophylline at 1 week. Started Jan 2017; status: completed.
02
Drugs
theophylline
03
Conditions
chronic obstructive pulmonary disease (COPD)
Beyond the preview
Go deeper on NCT03015090.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03015090.